Maxwell Biosciences: Funding, Investors & Team (Sep 2026)
Maxwell Biosciences is a company in the early stages of drug development, working on a new biotechnology platform called CLAROMER. This platform produces small compounds that imitate peptides and can easily enter cells, making them different from larger molecules.
Maxwell Biosciences has raised $30.8M across 2 funding rounds on record, the most recent an undisclosed round of $20.0M announced in Aug 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Maxwell Biosciences Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Maxwell Biosciences Funding Rounds
Maxwell Biosciences raised $10.8M in a Seed announced in Mar 2022.
3.4 years later, an undisclosed round of $20.0M was announced in Aug 2025.
Maxwell Biosciences Founders and Leadership Team
Contact details for the Maxwell Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Maxwell Biosciences Funding Compared to Other Biotechnology Startups
Maxwell Biosciences' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Maxwell Biosciences in Biotechnology and Austin
Companies Similar to Maxwell Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Maxwell Biosciences Funding FAQs
What does Maxwell Biosciences do?
Maxwell Biosciences is a company in the early stages of drug development, working on a new biotechnology platform called CLAROMER. This platform produces small compounds that imitate peptides and can easily enter cells, making them different from larger molecules.
How much funding has Maxwell Biosciences raised?
Maxwell Biosciences has raised $30.8M across 2 rounds on record. The most recent is an undisclosed round of $20.0M announced in Aug 2025.
When did Maxwell Biosciences last raise funding?
Maxwell Biosciences' most recent funding round on record is an undisclosed round of $20.0M, announced in Aug 2025.
Who founded Maxwell Biosciences?
FundedIQ lists Joshua Mcclure (Founder) at Maxwell Biosciences.
Where is Maxwell Biosciences headquartered?
Maxwell Biosciences is based in Austin, Texas, United States.
How many employees does Maxwell Biosciences have?
Maxwell Biosciences is in the 11-50 employee band.
How does Maxwell Biosciences' funding compare to other Biotechnology startups?
Maxwell Biosciences' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Maxwell Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Maxwell Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.